高级检索
当前位置: 首页 > 详情页

Signals from the TAFA4-PTEN-PU.1 axis alleviate nasal allergy by modulating the expression of Fc epsilon RI in mast cells

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]Longgang Tradit Chinese Med Hosp, Shenzhen, Peoples R China [2]Beijing Univ, Chinese Med Shenzhen Hosp, Shenzhen, Peoples R China [3]Shenzhen Univ, Affiliated Hosp 3, Dept Respirol & Allergy, Shenzhen, Peoples R China [4]Guangdong Prov Reg Dis Key Lab, Shenzhen, Peoples R China [5]Guangdong Prov Reg Dis Key Lab, Inst Allergy & Immunol, State Key Lab Resp Dis Allergy Div, Shenzhen, Chin, Myanmar
出处:
ISSN:

关键词: nasal allergy mast cell IgE receptor neuropeptide immunity

摘要:
The high-affinity IgE receptor, Fc epsilon RI, plays a key role in the antigen-induced mast cell activation. Regulations for Fc epsilon RI are not yet well understood. TAFA4 is a molecule derived from neuron tissues, and has immune regulation functions. This study aims to clarify the role of TAFA4 in the regulation of Fc epsilon RI expression in mast cells. Nasal secretions were collected from patients with allergic rhinitis (AR) and healthy control (HC) subjects. TAFA4 levels of nasal secretions were evaluated by ELISA. A mouse model AR was developed using ovalbumin as the specific antigen. Negative correlation between TAFA4 and tryptase levels in nasal secretions was observed. TAFA4 could suppress the antigen-related mast cell activation. TAFA4 modulated the transcription of Fcer1g (Fc epsilon RI gamma gene) in mast cells. Signals from the TAFA4-PTEN-PU.1 axis restricted Fc epsilon RI expression in mast cells. Administration of TAFA4 attenuated experimental AR. TAFA4 suppressed the expression of Fc epsilon RI in mast cells of airway tissues. TAFA4 can down regulate the expression of Fc epsilon RI in mast cells to suppress experimental AR. The data suggest that TAFA4 has translation potential to be developed as an anti-allergy therapy. TAFA4 suppressed the expression of FceRI in mast cells of airway tissues. Signals from the TAFA4-PTEN-PU.1 axis restricted FceRI expression in mast cells. Administration of TAFA4 attenuated experimental AR.

基金:
语种:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2022]版:
大类 | 3 区 医学
小类 | 3 区 免疫学
最新[2025]版:
大类 | 4 区 医学
小类 | 4 区 免疫学
JCR分区:
出版当年[2021]版:
Q2 IMMUNOLOGY
最新[2023]版:
Q3 IMMUNOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2021版] 出版当年五年平均 出版前一年[2020版] 出版后一年[2022版]

第一作者:
第一作者机构: [1]Longgang Tradit Chinese Med Hosp, Shenzhen, Peoples R China [2]Beijing Univ, Chinese Med Shenzhen Hosp, Shenzhen, Peoples R China
共同第一作者:
通讯作者:
通讯机构: [3]Shenzhen Univ, Affiliated Hosp 3, Dept Respirol & Allergy, Shenzhen, Peoples R China [4]Guangdong Prov Reg Dis Key Lab, Shenzhen, Peoples R China [5]Guangdong Prov Reg Dis Key Lab, Inst Allergy & Immunol, State Key Lab Resp Dis Allergy Div, Shenzhen, Chin, Myanmar [*1]Department of Respirology & Allergy, Third Affiliated Hospital of Shenzhen University, Shenzhen, China [*2]Room A7-509, 1066 Xueyuan Blvd, Shenzhen, China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:2018 今日访问量:0 总访问量:645 更新日期:2024-07-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 广东省中医院 技术支持:重庆聚合科技有限公司 地址:广州市越秀区大德路111号